Re: immunomodulatory 비타민 d 결핍, 만성질환에 영향 2025년 nature

[문형철]

1. nature  
2. npj science of food  
3. review articles  
4. article

Vitamin D: recent advances, associated factors, and its role in combating non-communicable diseases

• Review Article
• Open access
• Published: 13 June 2025

Vitamin D: recent advances, associated factors, and its role in combating non-communicable diseases

• Deepika, 
• Anita Kumari, 
• Surender Singh, 
• Md Faruque Ahmad, 
• Debolina Chaki, 
• Vikram Poria, 
• Sandeep Kumar, 
• Neha Saini, 
• Nisha Yadav, 
• Neelam Sangwan, 
• Mona N. BinMowyna, 
• Zayed D. Alsharari, 
• Nahla Kambal, 
• Jae Han Min & 
• António Raposo 

npj Science of Food volume 9, Article number: 100 (2025) Cite this article

•  
•  
•  
•  

Abstract

The field of nutrigenomics has produced numerous studies indicating the impact of vitamin D on various disease conditions. Trace elements of this vitamin in the body play a significant role in the regulation of body metabolism. This immunomodulatory vitamin plays a role in management of both communicable (viz. respiratory illness like COVID-19 and Respiratory tract infections) and non-communicable diseases e.g., cancer, osteomalacia, diabetes, and cardiovascular diseases. Deficient levels, i.e., vitamin D deficiency in body can lead to the onset of chronic non-communicable illnesses. Vitamin D plays a direct and sometimes indirect role in the progression (when deficient) and prevention (when sufficient) of non-communicable diseases. This essential nutrient may be obtained through dietary intake or supplements. However, the absorption of it relies on various factors, including the presence of complementary nutrients, chemical forms, and external stimuli such as UV-B and a healthy gastrointestinal tract. This review discusses vitamin D absorption and its role in non-communicable diseases with updates on methods for eval‎uating and fortifying this vitamin in varied diets. We also briefly highlight recommended dietary allowances by age group, absorption difficulties, and its significance in non-communicable disorders.

영양유전체학 분야는 

비타민 D가 다양한 질병 상태에 미치는 영향을 보여주는 수많은 연구를 발표해 왔습니다. 

이 비타민의 체내 미량 원소는 

신체 대사 조절에 중요한 역할을 합니다. 

이 면역 조절 비타민은 

전염성 질환(예: 코로나19와 같은 호흡기 질환 및 호흡기 감염)과 

비전염성 질환(예: 암, 골연화증, 당뇨병, 심혈관 질환)의 관리에 역할을 합니다. 

This immunomodulatory vitamin plays a role in management of both communicable (viz. respiratory illness like COVID-19 and Respiratory tract infections) and non-communicable diseases e.g., cancer, osteomalacia, diabetes, and cardiovascular diseases

비타민 D 결핍은 

만성 비전염성 질환의 발병으로 이어질 수 있습니다. 

비타민 D는 결핍 시 

질병의 진행에 직접적 또는 간접적으로, 

충분할 경우 예방에 역할을 합니다. 

이 필수 영양소는 

식이 섭취나 보충제를 통해 얻을 수 있습니다. 

그러나 

비타민 D의 흡수에는 보완 영양소의 존재, 

화학적 형태, 자외선 B(UV-B)와 같은 외부 자극, 건강한 소화관 등 다양한 요인이 영향을 미칩니다. 

이 리뷰는 

비타민 D의 흡수 및 비전염성 질환에서의 역할을 논의하며,

 다양한 식이에서 이 비타민을 평가하고 강화하는 방법에 대한 최신 정보를 제공합니다. 

또한 연령별 권장 섭취량, 

흡수 어려움, 

비전염성 질환에서의 중요성을 간략히 강조합니다.

Similar content being viewed by others

Vitamin D supplementation vs. placebo and incident type 2 diabetes in an ancillary study of the randomized Vitamin D and Omega-3 Trial

Article Open access08 April 2025

Global Perspective of the Vitamin D Status of African-Caribbean Populations: A Systematic Review and Meta-analysis

Article Open access19 July 2021

Vitamin D level as a predictor of dysmobility syndrome with type 2 diabetes

Article Open access26 August 2024

Introduction

Vitamins are essential for cellular health and function. This makes them essential for the body’s immunopathological and physiological responses and a significant micronutrients required for proper bodily function. This fat-soluble vitamin, which is primarily produced endogenously in human skin, exists in two major forms, namely ergocalciferol (D2) and cholecalciferol (D3). A substance called 7-dehydrocholesterol is transformed into vitamin D3 when the skin’s cutaneous layer gets exposed to ultraviolet-B light. Salmon, mackerel, mushrooms, and cod liver oil are some limited natural sources of this vitamin. However, D2 or D3, which are regarded as equivalent in increasing the body’s levels of vitamin D, may be found in marketed supplements1. Certain foods like cereals, soymilk, canned milk, and dairy produce are currently fortified with vitamin D, and therefore consumption of fortified foods might aid an individual achieve the recommended dietary allowances (RDAs) levels2.

No widely accepted standards for the ideal cut-off levels of vitamin D have been developed. However, dosage formulations are specified in international units, with one equivalent to 0.025ug of vitamin D3,4. A serum level of 25(OH)D, an inactive precursor to vitamin D is analysed to determine an individual’s vitamin D status5. Vitamin D deficiency or insufficiency leads to an increase in risk factors for non-communicable diseases (NCDs), such as cardiovascular diseases (CVDs), acute respiratory distress syndrome (ARDS), renal diseases and cancer6. Several researchers have described vitamin D as an immunomodulator as it supresses, modulate, and regulate innate and adaptive immune cells’ activities7,8,9,10. In a research plan, supplementation of vitamin D in liver allograft recipients reported a decrease in likelihood of acute cellular rejection and increased immunological tolerance (Zhou et al. 11).

비타민은

세포의 건강과 기능에 필수적입니다.

이는 신체 면역 반응과 생리적 반응에 필수적이며,

적절한 신체 기능에 필요한 중요한 미량 영양소입니다.

이 지용성 비타민은

주로 인간 피부에서 내생적으로 생성되며,

에르고칼시페롤(D2)과 콜레칼시페롤(D3)이라는

두 가지 주요 형태로 존재합니다. (D3)로 존재합니다.

피부 표피층이 자외선-B 광선에 노출될 때

7-데히드로콜레스테롤이라는 물질이 비타민 D3로 변환됩니다.

연어, 고등어, 버섯, 대구 간유 등은

이 비타민의 제한된 자연적 원천입니다.

그러나 D2 또는 D3는 신

체 내 비타민 D 수치를 증가시키는 데 동일하게 효과적이며,

시중에서 판매되는 보충제에서 발견될 수 있습니다1.

시리얼, 두유, 캔 밀크, 유제품 등 일부 식품은

현재 비타민 D로 강화되어 있으며,

따라서 강화 식품의 섭취는 개인이 권장 식이 섭취량(RDAs) 수준을 달성하는 데 도움을 줄 수 있습니다2.

비타민 D의 이상적인 기준치에 대한 널리 인정된 기준은

아직 개발되지 않았습니다.

그러나

용량 공식은 국제 단위로 지정되며,

1단위는 비타민 D 0.025ug에 해당합니다3,4.

비활성 전구체인 25(OH)D 혈청 농도를 분석하여

개인의 비타민 D 상태를 평가합니다5.

비타민 D 결핍 또는 부족은

심혈관 질환(CVDs), 급성 호흡곤란 증후군(ARDS), 신장 질환 및 암과 같은

비전염성 질환(NCDs)의 위험 요소를 증가시킵니다

급성 호흡곤란 증후군(ARDS), 신장 질환 및 암6과 같은

위험 요인이 증가합니다.

여러 연구자들은

비타민 D가 선천적 및 적응성 면역 세포의 활동을

억제, 조절, 조절함으로써 면역 조절제로 작용한다고 설명했습니다7,8,9,10.

연구 계획에서 간 이식 수혜자에게 비타민 D 보충을 투여한 결과

급성 세포 거부 반응의 발생 가능성이 감소하고

면역학적 내성이 증가했다는 보고가 있습니다(Zhou et al. 11).

NCDs are often regarded as chronic medical disorders with gradual progression and comprise a wide range of mental, gastroenterological, renal, hepatic, and neurological medical conditions. These non-infectious ailments are influenced by several variables, such as a person’s physiology, genetics, age, and environment12,13. Most of the death counts are for CVDs followed by cancer and respiratory disorders annually. There are 17.9 million global fatalities from CVDs, followed by 9.3 million from cancer and 4.1 million from respiratory diseases, with around 80% of these annual deaths occurring in people under the age of 7014. The past few years have witnessed a significant surge in COVID-19 cases around the world. Corroborations indicating an association between Vitamin D levels and COVID-19 in patients has been acquired through a review of numerous case studies, clinical trials, and ecological research10,15 and nearly 80% of COVID-19 patients were vitamin D deficient16. Similarly, vitamin D deficiency leads to the onset of diabetes in obese individuals17, and its rate of progression can be significantly reduced by ≥75 nmol/L supplements of vitamin D18. However, the crucial question is whether low vitamin D levels are only a marker for disease severity or they act as a distinct, modifiable factor that can be improved with external dosage supplementation3,19. The present review was designed considering the preval‎ence, sources, advisory guidelines, and disease co-relation to vitamin D. The popular search engines such as google scholar, JSTOR, and research gate were explored using the key words “hypovitaminosis D”, “vitamin D”, “fortification”, “non-communicable diseases (NCDs)”, “dietary guidelines”, and “absorption mechanism”. The studies identified through these keywords were selected and included for further collection of facts, figures, and data sources for the review. The studies wherein the correlation of vitamin D was not researched with NCD were excluded from the section vitamin D association with NCDs. Further, studies published before 2004 were excluded for direct inclusion. Researched studies focused on conventional methodologies were excluded from inclusion in the review. It was also ensured that the latest significant outputs for every section are covered while selecting the papers for review study. Studies for conflicting evidences were also searched and included wherever applicable. The publication time frame filter was defined from 2009-2024. The included citations beyond this time frame were considered for significant historical insights only.

NCDs는 점진적으로 진행되는 만성 의료 질환으로,

정신적, 소화기, 신장, 간, 신경학적 질환 등

다양한 의료 조건을 포함합니다.

이러한 비감염성 질환은

개인의 생리학, 유전적 요인, 연령, 환경 등

여러 변수에 의해 영향을 받습니다12,13.

연간 사망자의 대부분은 CVDs로,

그 다음으로 암과 호흡기 질환이 차지합니다.

전 세계적으로

심혈관 질환으로 인한 사망자는 1,790만 명,

암으로 인한 사망자는 930만 명,

호흡기 질환으로 인한 사망자는 410만 명이며,

이 중 약 80%는 70세 미만에서 발생합니다14.

최근 몇 년간

전 세계적으로 코로나19(COVID-19) 사례가 급증했습니다.

비타민 D 수치와 코로나19 사이의 연관성을 보여주는 증ㅇ거는

수많은 사례 연구, 임상 시험, 생태학적 연구를 검토한 결과 획득되었습니다10,15,

그리고

코로나19 환자의 약 80%가 비타민 D 결핍 상태였습니다1

마찬가지로, 비타민 D 결핍은

비만 환자의 당뇨병 발병을 유발하며17,

비타민 D 보충제(≥75 nmol/L)를 투여하면 진행 속도가 크게 감소할 수 있습니다18.

그러나 핵심 질문은

비타민 D 수치가 질병의 중증도를 나타내는 지표일 뿐인지,

아니면 외부 투여를 통해 개선 가능한 독립적인 수정 요인인지 여부입니다3,19.

본 리뷰는

비타민 D의 유병률, 공급원, 권장 지침, 질병과의 연관성을 고려하여 설계되었습니다.

구글 스칼라, JSTOR, 리서치 게이트와 같은 주요 검색 엔진을 사용하여 “비타민 D 결핍”, “비타민 D”, ‘강화’, “비전염성 질환(NCDs)”, “식사 지침”, “흡수 메커니즘”이라는 키워드로 검색을 진행했습니다.. 이러한 키워드를 통해 식별된 연구들은 검토를 위해 사실, 수치, 데이터 소스를 수집하기 위해 선정 및 포함되었습니다. 비타민 D와 NCD 간의 상관관계를 연구하지 않은 연구들은 “비타민 D와 NCD의 연관성” 섹션에서 제외되었습니다. 또한 2004년 이전에 발표된 연구들은 직접 포함에서 제외되었습니다. 전통적인 방법론을 사용한 연구는 검토에 포함되지 않았습니다. 각 섹션에서 최신 중요한 결과를 포함하도록 논문을 선정할 때도 이 점을 확인했습니다. 상반된 증거를 제시한 연구도 검색되어 적용 가능한 경우 포함되었습니다. 출판 기간 필터는 2009년부터 2024년까지로 정의되었습니다. 이 기간을 초과한 인용문은 중요한 역사적 통찰을 위해만 고려되었습니다.

Preval‎ence of vitamin D deficiency

Vitamin D has a dual role as a nutrient and as a hormone. It is essential for promoting calcium absorption, maintaining phosphate levels for healthy bone mineralization, and preventing hypocalcemic tetany. Studies obtained from the US database of the National Institutes of Health; however, indicate that vitamin D deficiency as an “under-recognized global health issue”20,21. The recommended daily intake for individuals up to the age of 70 is 600 IU, or 15 mcg. However, inadequate vitamin D intake acts as a risk factor for several health issues after the age of 71 (NIH22,). In contrast, Poland recommends an intake of 1000–2000IU per day for the age group of 11-65 years and 2000-4000IU for individuals over 75 years of age23. According to the Centres for Disease Control and Prevention in the USA, a 60% reduction in 25(OH)D levels was seen in white adults until 1994 and around 30% between 2001 and 2004, whereas it was about 10% and 5% in Africans Americans during the same periods24. A population of approximately 4,500 individuals over the age of 20 was studied by ref. 25, reporting a 41.6% preval‎ence of vitamin D deficiency in US adults. Globally, low- and middle- income and developing nations have a more widespread severe vitamin D deficiency (i.e. 25(OH)D levels <30 nmol/L). Europe has the highest preval‎ence rates of vitamin D deficiency among developed nations, with 40–53% of its citizens having 25(OH)D levels <50 nmol/L and 13-18% suffering from a severe deficiency (Cashman et al. 26; Cui et al. 27; Schoor & Lips28,). Canada and the United States follow with 37% and 7.4%29 and 24% and 5.9%, respectively Schleicher et al. 30, which are influenced by the age and genetics of the population3. Germany and the United Kingdom are two European nations where individuals of all ages are more likely to have blood serum 25(OH)D concentrations below 25/30 nmol/L. Adults (18–60 years old) from Portugal and Ireland tend to have lesser 25(OH)D levels21. However, older ( > 60 years) people in Portugal showed a higher frequency of vitamin D insufficiency21. Apart from age, race, and ethnicity, a patient’s medical condition, such as renal failure, liver disease, and transplant history, contribute to a high preval‎ence of Vitamin D deficiency Courbebaisse et al. 31; Vos et al. 32; Zhou et al. 19. India has the highest preval‎ence of vitamin D deficiency among major Asian nations, with blood serum 25(OH)D levels below 50 nmol/L (82.67%), followed by Pakistan (63.75%), Korea (62.15%), China (59.7%), and Japan (53.6%) (Schoor & Lips28,). Young Indian women within the investigated population had a greater incidence of severe Vitamin D deficiency ( < 25 nmol/L) than other Asian women33. Figure 1 represents the preval‎ence of deaths due to NCDs in America, Europe, South-East Asia, and India.

비타민 D 결핍의 유병률

비타민 D는

영양소와 호르몬의 이중 역할을 합니다.

칼슘 흡수 촉진,

건강한 골 미네랄화 위해 인산염 수치 유지,

저칼슘혈증성 경련 예방에 필수적입니다.

미국 국립 보건원(NIH) 데이터베이스에서 얻은 연구 결과에 따르면,

비타민 D 결핍은 “인식되지 않은 전 세계적 건강 문제”로 지목되었습니다.20,21.

70세 이하 개인의 권장 일일 섭취량은

600 IU 또는 15mcg입니다.

그러나

71세 이후 비타민 D 섭취 부족은

여러 건강 문제의 위험 요인으로 작용합니다. (NIH22,).

반면 폴란드는

11~65세 연령층에 하루 1000~2000IU,

75세 이상 개인에게는 2000~4000IU의 섭취를 권장합니다23.

미국 질병통제예방센터(CDC)에 따르면,

1994년까지 백인 성인에서 25(OH)D 수치가 60% 감소했으며,

2001년부터 2004년까지 약 30% 감소했습니다.

반면 같은 기간 아프리카계 미국인에서는 약 10%와 5% 아프리카계 미국인에서는 같은 기간 동안 약 10%와 5%였습니다.24. 20세 이상 약 4,500명을 대상으로 한 연구(참조 25)에서는 미국 성인에서 비타민 D 결핍의 유병률이 41.6%로 보고되었습니다.

전 세계적으로 저소득 및 중소득 국가와 개발도상국에서는

심각한 비타민 D 결핍(즉, 25(OH)D 수치 <30 nmol/L)이

더 널리 퍼져 있습니다.

유럽은 선진국 중 비타민 D 결핍 유병률이 가장 높으며,

시민의 40–53%가 25(OH)D 수치 <50 nmol/L를 보이고

13-18%가 심각한 결핍을 겪고 있습니다(Cashman et al. 26; Cui et al. 27; Schoor & Lips28).

캐나다와 미국은 각각 37%와 7.4%29, 24%와 5.9%30로 뒤를 이으며,

이는 인구 연령과 유전적 요인에 영향을 받습니다3.

독일과 영국은 유럽 국가 중 모든 연령층에서

혈청 25(OH)D 농도가 25/30 nmol/L 미만인 경우가

더 많은 두 국가입니다.

포르투갈과 아일랜드의 성인(18–60세)은

25(OH)D 수치가 낮은 경향이 있습니다21.

그러나

(60세 이상) 포르투갈 사람들은

비타민 D 결핍 빈도가 더 높았습니다21.

연령, 인종, 민족 외에도 환자의 의료 상태(신부전, 간 질환, 이식 이력 등)는

비타민 D 결핍의 높은 유병률에 기여합니다 Courbebaisse 등 31; Vos 등 32; Zhou et al. 19.

인도는 주요 아시아 국가 중 비타민 D 결핍 유병률이 가장 높으며,

혈청 25(OH)D 수치가 50 nmol/L 미만인 비율이 82.67%로 가장 높았고,

이어 파키스탄(63.75%), 한국(62.15%), 중국(59.7%), 일본(53.6%) 순이었습니다 (Schoor & Lips28,).

조사 대상 인구 중 젊은 인도 여성은

다른 아시아 여성보다 심각한 비타민 D 결핍(<25 nmol/L) 발생률이 더 높았습니다33.

그림 1은 미국, 유럽, 동남아시아, 인도에서

비전염성 질환(NCD)으로 인한 사망률 분포를 나타냅니다.

Fig. 1: Average number of deaths (in million), due to most common NCDs i.e.

Cardiovascular and respiratory diseases and diabetes in America (top left), Europe (top right), South-East Asia (bottom left) and India (bottom right) during 2009–2019. Adopted from: WHO, world health statistics. (This Figure was created by the authors).

Full size image

Low-to-middle income nations including Western Asia/Middle-East region with serum 25(OH)D < 25-30 nmol/L and Southern Asia with <20–25 nmol/L, are potential hotspots burdened with of vitamin D deficiency21. The data34regarding the counts of hypovitaminosis D in the Indonesian, Malaysian, Thai, and Vietnamese populations lend weight to this assertion as 31–44% of the population from these countries had vitamin D insufficiency, i.e., serum 25(OH)D levels between 25 and 50 nmol/L, and 0 to 11% had a severe deficiency, i.e., serum 25(OH)D levels below 25 nmol/L. Another study27 indicated that 22% of those in Southeast Asia have hypovitaminosis D. Indians living in the western portion of the country also exhibit a greater preval‎ence of hypovitaminosis D. Further, research co-related the poor dietary calcium consumption with vitamin D deficiency in the study population33.

혈청 25(OH)D가 25-30 nmol/L 미만인 서아시아/중동 지역과 20-25 nmol/L 미만인 남아시아를 포함한 저소득 및 중소득 국가들은 비타민 D 결핍으로 인한 부담이 높은 잠재적 위험 지역입니다.21 인도네시아, 말레이시아, 태국, 베트남 인구의 비타민 D 결핍증 사례 수에 대한 데이터는 이 주장을 뒷받침합니다. 이 국가들의 인구 중 31–44%가 비타민 D 결핍증(혈청 25(OH)D 수치 25–50 nmol/L)을 보였으며, 0–11%는 심각한 결핍증(혈청 25(OH)D 수치 25 nmol/L 미만)을 나타냈습니다. 또 다른 연구27에 따르면 동남아시아 인구의 22%가 비타민 D 결핍증을 겪고 있습니다. 인도 서부 지역에 거주하는 인도인들도 비타민 D 결핍증의 유병률이 더 높습니다. 또한 연구에서는 연구 대상 인구에서 칼슘 섭취 부족과 비타민 D 결핍 사이의 연관성을 확인했습니다33.

Vitamin D synthesis, regulation, and its intermediates in body

Vitamin D is a group of compounds derived from cholesterol. Vitamin D3 and D2, which are both produced by animals and plants, respectively, are the two types of vitamin D. The difference between the two is a methyl group on carbon 24 and an additional double bond between carbons 22 and 23 in the side chain of vitamin D235. The skin produces vitamin D3, which is the most important source in mammals. Vitamin D can be produced endogenously after exposure to ultraviolet-B (UVB) (290-315 nm), which converts 7-dehydrocholesterol, a form of cholesterol to vitamin D3 (cholecalciferol) in the dermal layers36,37. A specific kind of vitamin D-binding globulin carries vitamin D3 from the skin to the storage tissues or liver for 25 hydroxylation and conversion to 25(OH)D (calcidiol), a step that is probably catalysed by the liver cytochrome P450, CYP2R138. 25(OH)D is the primary vitamin D circulating in the body. It is metabolised by the mitochondrial cytochrome P450, CYP27B1, to the active form of vitamin D, 1α,25-dihydroxyvitamin D [1α,25(OH)2D] (calcitriol), largely in the kidneys39. Alternatively, the 24-hydroxylase enzyme CYP24 can convert 25(OH)D into 24,25(OH)2D40,41. Vitamin D is oxidised mostly by the enzyme CYP24A1, which converts 25(OH)D into 24,25(OH)2D and 1α,25(OH)2D into 1,24,25-trihydroxyvitamin D [1,24,25(OH)3D]35. Figure 2 shows a diagrammatic representation of this whole process. Vitamin D status is eval‎uated using biomarkers, which are molecules that can be detected in blood or other physiological fluids. 25(OH)D and 1,25(OH)2D are the two most often used biomarkers42. Given its stability and relatively lengthy half-life, 25(OH)D serves as an excellent long-term biomarker of vitamin D levels. The biologically active form of this nutrient, however, is 1,25(OH)2D, which is made in the kidneys from 25(OH)D43. 1,25(OH)2D levels are carefully managed by the body and do not represent vitamin D status generally. The blood levels of 25(OH)D and/or 1,25(OH)2D are assessed during a blood test to eval‎uate vitamin D biomarkers. The vitamin D status of an individual can then be eval‎uated using these levels to determine whether they are deficient, in-sufficient, or sufficient. Serum 25(OH)D can be quantified by various methods. The most commonly used are electrochemiluminescence immunoassay and enzyme-linked immunosorbent assay (ELISA). The cut-off value of <30 nmol/L has been set as deficient, 30-50 nmol/L as insufficient, and ≥50 nmol/L as sufficient44. In 2021, the Indian Academy of Paediatrics updated its guidelines on preventing and treating vitamin D deficiency, recommending 400 IU/day vitamin D supplements for infants. Children, adolescents, and the elderly estimated that average needs (400–600 IU/day, respectively) should be met through nutrition and naturally occurring sources such as sunlight. Oral cholecalciferol should be administered to treat rickets and vitamin D deficiency (2000 IU for infants and 3000 IU for children more than one year of age) for 12 weeks45.

비타민 D의 합성, 조절 및 체내 중간 대사산물

비타민 D는 콜레스테롤에서 유래한 화합물 그룹입니다. 동물과 식물에서 각각 생성되는 비타민 D3와 D2는 두 가지 유형의 비타민 D입니다. 두 유형의 차이는 비타민 D2의 측쇄에 있는 탄소 24에 메틸 그룹이 있고, 탄소 22와 23 사이에 추가적인 이중 결합이 존재한다는 점입니다35. 피부는 비타민 D3를 생성하며, 이는 포유류에서 가장 중요한 공급원입니다. 비타민 D는 자외선 B(UVB)(290-315nm)에 노출된 후 콜레스테롤의 한 형태인 7-데히드로콜레스테롤을 비타민 D3(콜레칼시페롤)로 전환하는 과정을 통해 체내에서 생성됩니다36,37. 특정 유형의 비타민 D 결합 글로불린은 비타민 D3를 피부에서 저장 조직이나 간으로 운반하여 25-하이드록시화 및 25(OH)D(칼시디올)로 전환됩니다. 이 과정은 간 사이토크롬 P450, CYP2R138에 의해 촉매될 가능성이 있습니다. 25(OH)D는 체내에서 순환하는 주요 비타민 D 형태입니다. 이는 미토콘드리아 사이토크롬 P450, CYP27B1에 의해 신장에서 주로 활성 형태의 비타민 D인 1α,25-디하이드록시비타민 D [1α,25(OH)2D] (칼시트리올)로 대사됩니다39. 대안적으로, 24-하이드록시화 효소 CYP24는 25(OH)D를 24,25(OH)2D로 전환시킬 수 있습니다40,41. 비타민 D는 주로 CYP24A1 효소에 의해 산화되며, 이 효소는 25(OH)D를 24,25(OH)2D로, 1α,25(OH)2D를 1,24,25-트리하이드록시비타민 D [1,24,25(OH)3D]로 전환합니다.35 그림 2는 이 전체 과정을 도식적으로 나타낸 것입니다. 비타민 D 상태는 혈액이나 다른 생리적 체액에서 검출될 수 있는 분자인 생물학적 지표(biomarker)를 사용하여 평가됩니다. 25(OH)D와 1,25(OH)2D는 가장 자주 사용되는 두 가지 생물학적 지표입니다42. 안정성과 상대적으로 긴 반감기 때문에 25(OH)D는 비타민 D 수치의 장기적 생물학적 지표로 우수합니다. 그러나 이 영양소의 생물학적 활성 형태는 25(OH)D에서 신장에서 생성되는 1,25(OH)2D입니다43. 1,25(OH)2D 수치는 신체에 의해 엄격히 조절되며, 일반적으로 비타민 D 상태를 반영하지 않습니다. 혈액 검사를 통해 25(OH)D와/또는 1,25(OH)2D의 혈중 농도를 측정하여 비타민 D 생체지표를 평가합니다. 이러한 수치를 바탕으로 개인의 비타민 D 상태를 부족, 부족하지 않음, 또는 충분함으로 평가할 수 있습니다. 혈청 25(OH)D는 다양한 방법으로 정량화될 수 있습니다. 가장 일반적으로 사용되는 방법은 전기화학 발광 면역 분석법과 효소 연결 면역 흡착 분석법(ELISA)입니다.

결핍은 <30 nmol/L, 부족은 30-50 nmol/L, 충분은 ≥50 nmol/L로 설정되었습니다44. 2021년 인도 소아과학회는 비타민 D 결핍의 예방 및 치료 지침을 업데이트하여 영아에게 하루 400 IU의 비타민 D 보충제를 권장했습니다. 어린이, 청소년, 노인층의 평균 필요량(각각 400–600 IU/일)은 영양 섭취와 자연 발생 소스(예: 햇빛)를 통해 충족되어야 합니다. 구강 콜레칼시페롤은 구루병 및 비타민 D 결핍을 치료하기 위해 12주 동안 투여해야 합니다(영아는 2000 IU, 1세 이상의 어린이는 3000 IU)45.

Fig. 2: Process of vitamin D synthesis and regulation in body.

(This Figure was created by the authors).

Full size image

Sources of vitamin D

Vitamin D is synthesized in the body from 7-dehydrocholesterol after exposure to sunlight, but this process also depends on the time of day, season, location, skin tone, and application of sunscreen46. Insufficient sunlight exposure, along with other factors such as dark skin, aging, obesity, low dietary intake, medications, malabsorption, and kidney or liver disorders, can result in a deficiency of this vitamin. Individuals may intake a vitamin D-rich diet or supplements to treat this deficiency. Vitamin D is present in both animal and plant-based food sources. Animal-based sources of vitamin D include cod liver oil, fatty fish such as salmon, tuna, and mackerel, egg yolks, cow liver, and fortified milk and dairy products like yoghurt and cheese, while mushroom accounts for the plant-based source for vitamin D (Guía-Galipienso et al. 47; Schmid & Walther48,). Although these foods are strong sources of vitamin D, it could be a challenge for certain individuals to receive enough of the vitamin purely from food sources, particularly if they follow a strict vegetarian or vegan diet. Two biomarkers, 25(OH)D and 1,25(OH)2D, are used to analyse or quantify vitamin D levels and content in animal-based foods. Various laboratory techniques, including ELISA and liquid chromatography-mass spectrometry (LC-MS/MS), can be employed to measure these biomarkers in nutritional products derived from animals49.

Obtaining vitamin D from plant-based sources can be a challenge as it is not naturally present in most of these foods50. Nevertheless, certain plant-based options, including plant-based milk substitutes and cereals, are fortified with this vitamin to provide this nutrient. Vitamin D2, a type of the vitamin obtained from plants, is frequently added to these products51. Additionally, some types of mushrooms naturally contain vitamin D2. Shiitake and portobello mushrooms, which have been exposed to UV light, have increased vitamin D2 concentrations. However, depending on how much UV exposure they receive, the amount of vitamin D2 in these mushrooms can vary significantly52. Many plant-based milks, including soy, almond, and oat milk, have vitamin D2 or D3 added to them. Other vitamin D-fortified food options available in the food industry include orange juice and fortified tofu, etc53.

Nutraceuticals, which are dietary supplements believed to have health benefits, can be a source of vitamin D. Various supplement forms of vitamin D are available, including gummies, tablets, and capsules54. The most popular vitamin D supplement is vitamin D3, which is often made from fish oil or lanolin, a wax found in sheep’s wool. Vitamin D supplement dosages can vary greatly, with common daily doses falling between 600 and 4000 IU55. In addition to serving as a vitamin D supplement, cod liver oil is also a source of other nutrients such as omega-3 fatty acids56. Along with other necessary vitamins and minerals, vitamin D is a common ingredient in multivitamin supplements. The amount of vitamin D in multivitamins varies depending on the brand and formulation57.

비타민 D의 원천

비타민 D는 햇빛에 노출된 후 7-데히드로콜레스테롤에서 체내에서 합성되지만, 이 과정은 하루 중 시간, 계절, 위치, 피부 색소, 자외선 차단제 사용 여부 등에 따라 달라집니다46. 햇빛 노출 부족, 피부 색소, 노화, 비만, 식이 섭취 부족, 약물 복용, 흡수 장애, 신장 또는 간 질환과 같은 요인으로 인해 이 비타민의 결핍이 발생할 수 있습니다. 결핍을 치료하기 위해 비타민 D가 풍부한 식이 또는 보충제를 섭취할 수 있습니다. 비타민 D는 동물성 및 식물성 식품 모두에 존재합니다. 동물성 비타민 D 원천에는 대구 간유, 연어, 참치, 고등어와 같은 지방이 많은 생선, 계란 노른자, 소 간, 강화 우유 및 유제품(요구르트, 치즈 등)이 있으며, 식물성 원천으로는 버섯이 있습니다(Guía-Galipienso et al. 47; Schmid & Walther48). 이러한 식품은 비타민 D의 강력한 공급원이지만, 특히 엄격한 채식주의나 비건 식단을 따르는 경우 식품만으로 충분한 양을 섭취하는 것이 어려울 수 있습니다. 동물성 식품의 비타민 D 수준과 함량을 분석하거나 측정하기 위해 25(OH)D와 1,25(OH)2D라는 두 가지 생물학적 지표가 사용됩니다. ELISA와 액체 크로마토그래피-질량 분석법(LC-MS/MS)과 같은 다양한 실험실 기술은 동물성 식품에서 유래한 영양 제품에 포함된 이러한 생물학적 지표를 측정하는 데 활용될 수 있습니다49.

식물성 식품에서 비타민 D를 얻는 것은 대부분의 이러한 식품에 자연적으로 존재하지 않기 때문에 어려울 수 있습니다50. 그럼에도 불구하고, 식물성 우유 대체품과 시리얼 등 일부 식물성 식품은 이 비타민을 강화하여 이 영양소를 공급합니다. 식물에서 얻은 비타민 D의 한 유형인 비타민 D2는 이러한 제품에 자주 추가됩니다51. 또한 일부 버섯은 자연적으로 비타민 D2를 함유합니다. 자외선에 노출된 시イタ케와 포트벨로 버섯은 비타민 D2 농도가 증가합니다. 그러나 자외선 노출량에 따라 이러한 버섯의 비타민 D2 함량은 크게 달라질 수 있습니다52. 식물성 우유(콩, 아몬드, 오트밀 등)에는 비타민 D2 또는 D3가 추가되어 있습니다. 식품 산업에서 판매되는 다른 비타민 D 강화 식품에는 오렌지 주스, 강화 두부 등이 있습니다53.

건강에 이로운 것으로 알려진 영양 보조제인 뉴트리션 제품도 비타민 D의 원천이 될 수 있습니다. 비타민 D 보조제는 껌, 정제, 캡슐 등 다양한 형태로 판매됩니다54. 가장 인기 있는 비타민 D 보충제는 비타민 D3로, 주로 어유나 양모에서 추출된 란놀린에서 만들어집니다. 비타민 D 보충제의 용량은 크게 다를 수 있으며, 일반적인 일일 용량은 600~4,000 IU55입니다. 비타민 D 보충제 외에도, 고등어 간유는 오메가-3 지방산 등 다른 영양소의 원천이기도 합니다56. 비타민 D는 다른 필수 비타민과 미네랄과 함께 종합 비타민 보충제의 일반적인 성분입니다. 종합 비타민에 함유된 비타민 D의 양은 브랜드와 제형에 따라 다릅니다57.

Vitamin D estimation in food samples

Preparation of the sampling process plays a significant role in vitamin D estimation in food samples. Sample pretreatment is required for extraction from the sample matrices, filtration, and concentration before analytical estimation of vitamin D. Sample extraction is employed to liberate the fragments from sample matrices and remove the co-existing contaminants58. Protein precipitation and saponification are the methods used for sample extraction. For milk and milk products, protein precipitation is generally used, and mostly acetonitrile acts as a precipitant. Saponification is a lipid-removal technique for the extraction of vitamin D in foodstuffs. Successive cleanup and enhancement are needed for the samples to improve sensitivity and selectivity of the methods. Studies reported liquid-liquid extraction (LLE), solid phase extraction (SPE), magnetic solid-phase extraction (MSPE), dispersive liquid-liquid microextraction (DLLME), supported liquid extraction (SLE), hollow fibre-liquid phase microextraction (HF-LPME), dissolved carbon-dioxide flotation-emulsification microextraction (DCF-EME), and supercritical fluid chromatography (SFC) pretreatment methods for vitamin D analysis58,59.

High-performance liquid chromatography (HPLC) is one of the techniques for estimating vitamin D in food samples. High-performance liquid chromatography (HPLC) is a column chromatography that has two phases, namely, mobile phase and stationary phase. HPLC is a separation technique that separates, identifies, and quantifies each component in a mixture. The yield in HPLC is higher when compared to traditional column chromatography because the mobile phase is pumped at high pressure. Various studies have depicted the usage of HPLC for estimating vitamin D in food samples60. used LDS-DLLME (low-density solvent-based dispersive liquid-liquid microextraction) succeeded by the HPLC method in milk and yoghurt drink samples to estimate cholecalciferol (vitamin D3). This experiment showed high relative recovery and linearity, reduced extraction time, and the relative standard deviation was observed to be less than 7.5%. Thus, the technique was considered competent for vitamin D3 estimation in fortified milk and yoghurt drink samples60. In another study estimating vitamin D3 in milk samples, the salting-out assisted liquid-liquid extraction (SALLE) technique was administered to extract the vitamin, followed by HPLC. Acetonitrile, ammonium sulphate, and vitamin D2 acted as a solvent for extraction, a salting-out agent, and internal standard, respectively. Good linearity with a detection limit of 15 ng/g, a quantitation limit of 25 ng/g, and spiked recoveries ranging from 94.4 to 113.5% were observed61. Cholecalciferol was estimated in cereal samples using ultrasonic-assisted extraction, followed by dispersive liquid-liquid microextraction (UAE-DLLME) in the preconcentration step, and HPLC was employed. High linearity ranging from 2 to 500 ng/g, a relative standard deviation of 6.2%, a detection limit of 0.7 ng/g, and a limit of quantitation of 2.1 ng/g were observed. Spiked recoveries of wheat flour and bread samples ranged from 87% to 98%. Thus, the proposed method showed better results compared to other methods of analysis and is therefore recommended for estimating vitamin D3 in cereal samples62. UV-Vis detector (UVD) was also occasionally observed for quantitative analysis. In another recent study, fat-soluble vitamins in rice cereal baby foods were determined using two liquid chromatographic systems: ultra-high performance liquid chromatography (UHPLC-APCI-MS/MS) and HPLC-DAAD. C18 columns and methanol-acetonitrile, acting as a mobile phase, were used for separation. The recoveries ranged from 95.2 to 106% for cholecalciferol, and relative standard deviation of 6.4 to 15% was observed63. The HPLC method requires rigorous pretreatment to prevent the effects of strong matrix in complex samples, which could affect the precision of the analysis. The similar structure and chemical properties of vitamin D species are difficult to distinguish by this method. HPLC methods are applied to a relatively high concentration of vitamin D, as it might not detect the trace level in samples. Vitamin D estimation was also performed by the LC-MS method due to its high accuracy, sensitivity, precision, flexibility, and resolution. LC-MS is an analytical technique that combines physical separation capabilities of liquid chromatography with analysis of mass-by-mass spectrometry, i.e., it includes separation power and detection power of HPLC and mass spectrometry, respectively. In most cases, the interface used is an ionisation source. This method is considered as a correct standard for serum 25(OH)D estimation and can distinguish between 25(OH)D2, ergocalciferol and 25(OH)D3, and cholecalciferol59. Vitamin A, D, E estimation in food samples were obtained simultaneously by a combined method of online solid phase extraction and heart-cutting two-dimensional liquid chromatography (2DLC). After saponification, the solution was introduced into the system combining online SPE and heart-cutting 2DLC, where it was enriched, purified, separated, and quantified. Vitamin D analysis was obtained with the help of polycyclic hydrocarbon (PAH) as a second column. The results observed were linear; spiked recoveries ranged from 93.29% to 103.66%, and quantification limit of vitamin D2, D3 were 0.013 ng and 0.014 ng, respectively. Thus, the suggested method was observed to enhance efficiency, making the workflow easier64. Vitamin D3-like activity is observed in some plants, which had led to calcium intoxication in grazing animals. In another study estimating vitamin D3 and sterol precursors, its effect on UV treatment in plants was performed using LC-MS/MS, along with atmospheric pressure chemical ionisation (APCI) technique. The PHP (Pentaflurophenyl) column, being less hydrophobic, was used for faster separation than the C10 or C8 column. Recoveries ranging from 101 to 114%, precision of 3 to 12%, and a limit of detection 2-8 ng/g were observed. Thus, the recommended method was observed to be useful in vitamin D and sterol estimation in plants. In a pilot study, UV treatment resulted in the observation of vitamin D3 in S. glaucohyllum Desf. and S. lycopersicum L., indicating vitamin D3 formation requires light exposure65. A study was recently performed to determine the content of mycotoxins, hormones, and fat-soluble vitamins in chicken egg yolks. On-line sample clean-up was performed using the LC-MS/MS procedure combined with dilute/precipitate and centrifuge shoot process for multi-class estimation of egg yolks. Good linearity, detection limits, and quantitation was observed, along with low level of mycotoxins and variation in fat-soluble vitamin content66.

식품 시료에서의 비타민 D 추정

식품 시료에서의 비타민 D 추정에서 시료 채취 과정의 준비는 중요한 역할을 합니다. 샘플 추출, 필터링, 농축을 통해 비타민 D 분석 전 샘플 매트릭스에서 성분을 분리하기 위해 샘플 전처리가 필요합니다. 샘플 추출은 샘플 매트릭스에서 성분 조각을 분리하고 공존하는 오염 물질을 제거하기 위해 사용됩니다58. 단백질 침전과 사포니피케이션은 샘플 추출에 사용되는 방법입니다. 우유 및 유제품의 경우 단백질 침전이 일반적으로 사용되며, 주로 아세토니트릴이 침전제로 작용합니다. 사포니피케이션은 식품에서 비타민 D를 추출하기 위한 지질 제거 기술입니다. 방법의 감도와 선택성을 향상시키기 위해 시료에 대한 연속적인 정제 및 강화 과정이 필요합니다. 연구에서는 액체-액체 추출(LLE), 고체 상 추출(SPE), 자기 고체 상 추출(MSPE), 분산 액체-액체 미세 추출(DLLME), 지지체 액체 추출 (SLE), 중공 섬유 액체 상 미세 추출(HF-LPME), 용해된 이산화탄소 부상-유화 미세 추출(DCF-EME), 초임계 유체 크로마토그래피(SFC) 전처리 방법을 보고했습니다58,59.

고성능 액체 크로마토그래피(HPLC)는 식품 시료에서 비타민 D를 추정하는 기술 중 하나입니다. HPLC는 이동상(mobile phase)과 고정상(stationary phase)의 두 상으로 구성된 컬럼 크로마토그래피입니다. HPLC는 혼합물 내 각 성분을 분리, 식별, 정량화하는 분리 기술입니다. HPLC의 수율은 전통적인 컬럼 크로마토그래피에 비해 이동상이 고압으로 펌핑되기 때문에 더 높습니다. 다양한 연구에서 식품 시료에서 비타민 D를 추정하기 위해 HPLC의 사용을 보고했습니다60. LDS-DLLME(저밀도 용매 기반 분산 액체-액체 미세 추출)를 사용한 후 HPLC 방법을 적용하여 우유와 요거트 음료 시료에서 콜레칼시페롤(비타민 D3)을 추정했습니다. 이 실험은 높은 상대 회수율과 선형성, 추출 시간 단축을 보여주었으며, 상대 표준 편차는 7.5% 미만으로 관찰되었습니다. 따라서 이 기술은 강화 우유 및 요거트 음료 시료에서 비타민 D3 추정용으로 적합하다고 판단되었습니다60. 다른 연구에서 우유 시료의 비타민 D3 추정 시, 염분 침전 보조 액체-액체 추출(SALLE) 기술을 사용하여 비타민을 추출한 후 HPLC를 적용했습니다. 아세토니트릴, 암모늄 황산염, 비타민 D2는 각각 추출 용매, 염화물 침전제, 내부 표준으로 사용되었습니다. 15 ng/g의 검출 한계, 25 ng/g의 정량 한계, 94.4~113.5%의 첨가 회수율을 나타내는 우수한 선형성이 관찰되었습니다61. 초음파 보조 추출을 통해 곡물 시료에서 콜레칼시페롤을 추출한 후, 전농축 단계에서 분산 액체-액체 미세 추출(UAE-DLLME)을 수행하고 HPLC를 적용했습니다. 2~500 ng/g 범위에서 높은 선형성, 상대 표준 편차 6.2%, 검출 한계 0.7 ng/g, 정량 한계는 2.1 ng/g로 관찰되었습니다. 밀 가루와 빵 시료의 첨가 회수율은 87%에서 98% 사이였습니다. 따라서 제안된 방법은 다른 분석 방법보다 우수한 결과를 보여주었으며, 따라서 곡물 시료에서 비타민 D3를 추정하는 데 권장됩니다62. UV-Vis 검출기(UVD)도 정량 분석에 간혹 사용되었습니다. 최근 다른 연구에서는 쌀 시리얼 유아 식품의 지용성 비타민을 초고성능 액체 크로마토그래피(UHPLC-APCI-MS/MS)와 HPLC-DAAD 두 가지 액체 크로마토그래피 시스템을 사용하여 측정했습니다. 분리에는 C18 컬럼과 메탄올-아세토니트릴을 이동상으로 사용했습니다. 콜레칼시페롤의 회수율은 95.2%에서 106% 사이였으며, 상대 표준 편차는 6.4%에서 15%로 관찰되었습니다63. HPLC 방법은 복잡한 시료에서 강한 매트릭스의 영향을 방지하기 위해 엄격한 전처리가 필요하며, 이는 분석의 정밀도에 영향을 줄 수 있습니다. 비타민 D 종의 유사한 구조와 화학적 특성으로 인해 이 방법으로 구분하기 어렵습니다. HPLC 방법은 비타민 D의 상대적으로 높은 농도에 적용되며, 시료 내 미량 수준을 검출하지 못할 수 있습니다. 비타민 D 측정은 높은 정확도, 민감도, 정밀도, 유연성, 및 분해능을 갖춘 LC-MS 방법으로 수행되었습니다. LC-MS는 액체 크로마토그래피의 물리적 분리 능력과 질량 분광 분석을 결합한 분석 기술로, 각각 HPLC의 분리 능력과 질량 분광계의 검출 능력을 포함합니다. 대부분의 경우 이온화 소스가 인터페이스로 사용됩니다. 이 방법은 혈청 25(OH)D 측정용 정확한 표준 방법으로 간주되며, 25(OH)D2, 에르고칼시페롤 및 25(OH)D3, 콜레칼시페롤을 구분할 수 있습니다59. 식품 시료에서의 비타민 A, D, E 측정치는 온라인 고체상 추출과 심장 절단 2차원 액체 크로마토그래피(2DLC)를 결합한 방법으로 동시에 얻어졌습니다. (2DLC)를 통해 동시에 측정되었습니다. 사포니피케이션 후, 용액은 온라인 SPE와 심장 절단 2DLC를 결합한 시스템에 도입되어 농축, 정제, 분리, 정량화되었습니다. 비타민 D 분석은 다환 방향족 탄화수소(PAH)를 제2 컬럼으로 사용하여 수행되었습니다. 관찰된 결과는 선형성을 보였으며, 첨가 회수율은 93.29%에서 103.66% 사이였고, 비타민 D2 및 D3의 정량 한계는 각각 0.013 ng 및 0.014 ng였습니다. 따라서 제안된 방법은 효율성을 향상시켜 작업 흐름을 단순화하는 것으로 관찰되었습니다64. 일부 식물에서 비타민 D3 유사 활성이 관찰되었으며, 이는 방목 동물에서 칼슘 중독을 유발했습니다. 다른 연구에서 비타민 D3 및 스테롤 전구체의 추정 시 식물에서의 자외선 처리 효과를 LC-MS/MS와 대기압 화학 이온화(APCI) 기술을 사용하여 평가했습니다. PHP(펜타플루오로페닐) 컬럼은 C10 또는 C8 컬럼보다 덜 친수성으로 더 빠른 분리를 위해 사용되었습니다. 회수율은 101~114%, 정밀도는 3~12%, 검출 한도는 2~8 ng/g로 관찰되었습니다. 따라서 이 방법은 식물에서의 비타민 D 및 스테롤 추정에서 유용한 것으로 확인되었습니다. 시범 연구에서 자외선 처리는 S. glaucohyllum Desf. 및 S. lycopersicum L.에서 비타민 D3를 관찰했으며, 이는 비타민 D3 형성에 빛 노출이 필요함을 나타냅니다65. 최근 닭 계란 노른자에서 마이코톡신, 호르몬, 지용성 비타민의 함량을 결정하기 위한 연구가 수행되었습니다. 다중 클래스 추정 위해 LC-MS/MS 절차와 희석/침전 및 원심분리 과정을 결합한 온라인 시료 정제 방법이 적용되었습니다. 좋은 선형성, 검출 한계, 정량화가 관찰되었으며, 마이코톡신 함량이 낮고 지용성 비타민 함량의 변동성이 낮았습니다66.

Regulatories/RDA OF all age group for vitamin D

Dietary reference intakes (DRI) or dietary reference values (DRV) are terms used to describe vitamin D requirements for the general population. 25(OH)D in serum concentration is presumed to be a vitamin D biomarker. The cause-effect relationship of ingesting vitamin D and its effect on health is the objective of vitamin D recommendations. Generally, a dose-response relationship is characterised by serum 25(OH) concentrations on musculoskeletal health consequences and sometimes extra-skeletal health outcomes. A target 25(OH)D serum concentration is established, which is then used to calculate the estimated average requirement (EAR) and RDA of vitamin D. The daily nutrient intake level, on average, that is adequate to meet the requirement of half and 97.5% of healthy individuals at a certain life stage for different genders is defined as EAR and RDA, respectively. Harinarayan,67; Pilz et al. 68. The dietary reference intakes of various countries are shown in the Table 1. For Indians, the RDA for all age groups is 600 IU/day, except for children less than 12 months at 400 IU/day and the geriatric group at 800 IU/day. The Institute of Medicine for the US and Canada suggested an RDA for all age groups similar to that for Indians, except the geriatric age groups at aged over 70 years, for whom the RDA is 800IU/day. For Europe, EFSA has recommended an adequate intake (AI) for all age groups to be 600 IU/day, except for infants at 400 IU/day. The adequate intake (AI) for Germany, Austria, and Switzerland is suggested to be 800 IU/day for all age groups, except infants at 400 IU/day.

모든 연령층을 위한 비타민 D의 규제 기준/권장 섭취량

식이 참고 섭취량(DRI) 또는 식이 참고 값(DRV)은 일반 인구의 비타민 D 요구량을 설명하는 용어입니다. 혈청 25(OH)D 농도는 비타민 D의 생물학적 지표로 간주됩니다. 비타민 D 섭취와 건강에 미치는 영향의 인과 관계는 비타민 D 권장량의 목적입니다. 일반적으로 혈청 25(OH) 농도와 근골격계 건강 결과 사이의 용량-반응 관계가 특징이며, 때로는 골격 외 건강 결과에도 적용됩니다. 목표 혈청 25(OH)D 농도가 설정되며, 이는 비타민 D의 추정 평균 필요량(EAR)과 RDA를 계산하는 데 사용됩니다. 특정 생애 단계와 성별에 따라 건강한 개인의 50%와 97.5%가 요구량을 충족시키는 데 충분한 평균 일일 영양소 섭취 수준이 각각 EAR과 RDA로 정의됩니다. Harinarayan,67; Pilz et al. 68. 다양한 국가의 식이 참고 섭취량은 표 1에 표시되어 있습니다.

인도인의 경우 모든 연령층의 RDA는 600 IU/일이며, 12개월 미만의 영아는 400 IU/일, 노인층은 800 IU/일입니다. 미국과 캐나다의 의학연구소(IOM)는 인도와 유사한 RDA를 모든 연령층에 권장했으나, 70세 이상 노인층의 경우 RDA를 800 IU/일로 제시했습니다.

유럽의 경우 EFSA는 모든 연령층에 대한 적정 섭취량(AI)을 600 IU/일, 영아는 400 IU/일로 권장했습니다. 독일, 오스트리아, 스위스의 적정 섭취량(AI)은 모든 연령층에 대해 800 IU/일, 영아는 400 IU/일로 권장됩니다.

Table 1 Dietary reference values (DRV)/ dietary reference intakes (DRI) for vitamin D

Full size table

Vitamin D fortification advances

Vitamin D is volatile in nature. There are various methods to fortify vitamin D in foods, such as direct addition, direct irradiation, emulsification, microencapsulation, and nanoencapsulation (Bhuiyan et al. 69; Calvo & Whiting,70; Fennema71,). It is worth noting that the specific methods and regulations for vitamin D fortification may vary between countries. Additionally, the fortification levels may differ depending on the intended target population and the desired nutrient content. For example, fruit juices, particularly orange juice, are commonly fortified with vitamin D. This provides an additional option for individuals to obtain vitamin D through their beverage choices. Among the techniques, direct addition is a more reliable, recognised, and competent method for fortifying milk and milk products in the food industry. In direct addition, vitamin D is diffused into ethanol, which is a food-grade organic solvent, and butter oil. Then, uniform distribution is obtained by homogenising it into the food matrix. Vitamin D gets deposited in tetra-packs and becomes unstable due to deterioration in aqueous food matrix (Bhuiyan et al. 69). The emulsification technique of fortification requires two immiscible substances, and one is dispersed within another as droplets. Vitamin D is distributed as small droplets in water, which is then mixed with foods to be fortified like cheese, milk, and bread. In one study, milk protein acted as an emulsifier, incorporating vitamin D3 to develop fortified ice cream, thereby improving vitamin D3 stability72. The demerits of emulsification fortification techniques are instability, lack of homogeneity, and poor dispersibility. Therefore, stabilization is necessary through the use of surfactants and emulsifiers. Studies have shown that to overcome these challenges, methods such as emulsions using whey protein isolate (WPI), zein, casein, carboxymethyl chitosan, and medium-chain triglycerides have been employed for the development of vitamin D nanomaterials Bhuiyan et al. 69; Calvo and Whiting,70. Bio-addition is the process of enhancing a food staple with another food that is high in a particular nutrient. This, in contrast to biofortification, has been considered a novel approach to enriching foods with vitamin D. Studies have shown a rise in vitamin D2 levels in UV treated edible white button mushroom analogues, similar to vitamin D3 formation after sun exposure to the skin, exemplifying bio-addition (Bennink and Ono73). Fortification of vitamin D in the food industry is a major concern due to its instability, and non-uniform dispersion in food and limited bioavailability. During the storage and processing of vitamin D-fortified foods like milk, cheese, yoghurt and other milk products, oxidation, isomerisation, and poor retention are observed. In a study at different storage temperatures, the levels of vitamin B12 and vitamin D3 in fortified whole wheat flour were assessed along with relative humidity. Loss of both vitamins was observed with an increase of temperature during storage, and vitamin D3 loss was found to be due to relative humidity. Among the developed food products, chapatti obtained maximum vitamin B12 retention, while cake obtained maximum vitamin D3 retention. Frying led to minimal retention of both vitamins. Another study aimed to analyse the impact of vitamin D stability with respect to frying cycles and the absorption rate of vitamin D3 in two forms of fortified rice bran oil, i.e., batter and dough. The absorption rate was observed to be reduced in both the products after the first frying cycle. During frying, the absorption rate was found to be higher in dough-based products74. Some types of mushrooms, such as shiitake and maitake, have the ability to produce vitamin D when exposed to ultraviolet light. These mushrooms can offer a plant-based source of vitamin D. All the processing methods classified as cooking methods (baking, cooking, frying, boiling) showed significant loss of vitamin D75,76,77. To address these challenges, various innovative techniques, namely, UV-irradiation, nanoemulsion, and microencapsulation, have been adopted by food industries to fortify vitamin D. Microencapsulation, a commonly utilized technique, insulates the bioactive core material by secondary wall materials, creating a barrier and to protect the core from the external environment. Microencapsulation improves nutrient retention time, avoids chemical reactions, and enables controlled release of the encapsulant at the required time (Maurya et al. 78). Many food industries use this technique for the fortification of vitamins. In one study, fat-soluble vitamins (A, D, E) were microencapsulated using a one-pot ultrasonic process, and raw egg white protein acted as the shell material. The UV filtering property is induced to prevent photodegradation, and thus the green tea catechin coating method was developed. Antimicrobial properties, highly stable vitamins, long shelf life, shielding from denaturation by heat, UV irradiation, storage, and cooking were observed79. Spray drying is considered the oldest and most common method applied for encapsulating bioactive compounds. A dispersion or emulsion of vitamin D is prepared and homogenized, and then it is fed to a spray dryer, which is atomized in drying chamber with a spinning wheel or nozzle. During atomization, hot air evaporates water, and nanomaterials are formed. Studies have shown that liposomes help with vitamin D fortification in foods. The word “liposome” is obtained from two Greek words, “lipo” and “soma,” meaning “fat” and “structure,” respectively. Liposomes are spherical vesicles consisting of an aqueous phase enclosed by an amphiphilic phospholipid membrane, which can be single or multilayer77. The amphiphilic nature, flexibility in size and composition, and high biocompatibility with animal tissue are a few reasons why liposomes are the most adopted technique for microencapsulation of vitamin D (Aminullah Bhuiyan et al. 69; Handu,80,81; Zahedirad et al. 82).

Nanoencapsulation is a technique in which bioactive compounds are encapsulated at a nanoscale range. It escalates bioavailability and solubility, amplifies controlled release, permits precision targeting of bioactive compounds, and increases cellular uptake (Handu,80; Suganya and Anuradha76). The physiochemical and rheological properties of fortified foods remain unchanged. Fortification by nanoencapsulation is achieved through electro-spinning and electro-spraying. Electrospinning is a fibre-producing technique that draws charged fibre of polymer solutions by exerting electric force. Although the usage of the electrospinning technique is much less for thermosensitive bioactive agents, this technique is most appropriate69. Starches, sugars, fats, gums, chitosan, gelatin, and maltodextrin are used as coating materials for ingraining. Nanosuspensions, nanoliposomes, nanoemulsions, and cyclodextrin carriers are used as techniques for food fortification70,78. Acca sellowiana, an experimental jelly model, was fortified with nano-encapsulated vitamin D3. Suitable shelf life, encapsulation efficiency, positive physicochemical stability, increased content of bioactive compounds with antioxidant properties were observed. An 80% release was observed under the gastrointestinal release simulations, reaching the highest level in the duodenum. Thus, this can be a useful strategy for extending the residence duration of vitamin D3 (Melo et al. 80). In another study, vitamin D was encapsulated in fish oil using the ultrasonication technique via nano-emulsion, with a 95.7-98.2% encapsulation efficiency. Higher bioavailability of encapsulated vitamin D was observed compared to non-encapsulated vitamin D83. Thus, nanoencapsulation is a suitable method for vitamin D fortification.

Factors affecting absorption of vitamin D

Hollander et al. explained vitamin D absorption in the mid-1970s by establishing a relationship between the rate of absorption of vitamin D and its intraluminal concentrations, indicating the idea of passive diffusion. Recent studies have demonstrated that at low concentration, vitamin D absorption occurs through protein mediated transport, and at high concentration, it gets shifted to passive diffusion84. Studies have shown numerous factors affecting vitamin D absorption, namely, vitamin D forms, molecular linkage, food matrix and its complexity, state of vitamin D, lipids, dietary fibre, ageing, disease, and surgery.

Forms of vitamin D

The literature reports variation in bioavailability due to molecular forms of vitamin D. To understand the bioavailability of ergocalciferol and cholecalciferol, 50,000 IU single doses were administered to 20 healthy male subjects over a period of 28 days, and the same elevation pattern in serum 25(OH)D for two forms was observed. Similarly, another study was conducted on healthy adults aged 18–84 years for 11 weeks at the end of each winter, and vitamin D2 and D3 bioavailability from fortified orange juice and supplements was compared, but no significant difference was reported in this work without the confidence limit85. However, increased vitamin D3 absorption was observed in two clinical studies, which might be due to the rapid clearance activity of vitamin D2 compared to vitamin D3. In one study, the powdered form of vitamin D3 and the oil-based form of vitamin D2 were administered weekly through the ingestion 50,000 IU to subjects with cystic fibrosis. The skin of the subjects was exposed to a UV lamp 5 times per week, followed by the collection of serum 25(OH)D samples at 12th week. The solubility of the oil form was observed to be lower than that of the powdered form. Another clinical study by Romagnoli et al. 86 observed that after 60 days, vitamin D3 increased serum 25OHD in a nearly twice as effective manner as vitamin D286,87,88. Similarly, another study was conducted to observe the influence of vitamin D2 and D3 administration on vitamin D3 metabolism. Vitamin D2 was found to be incapable in increasing total serum 25(OH)D3 concentrations, reducing 25-hydroxylation and 1-alpha hydroxylation and increasing 24R-hydroxylation of 25(OH)D389. This conclusion was supported by another randomised controlled study conducted during the winter months on healthy South Asian and white European women, in which fortified juice or foods of vitamin D2 or D3 were administered, and their effect on serum 25(OH)D was observed. Vitamin D3 was observed to be more effective and to significantly increase absorption90. Vitamin D2 and vitamin D3 are the non-hydroxylated forms, while 25(OH)D3 is the hydroxylated form. Studies observed that when vitamin D (non-hydroxylated and hydroxylated) was administered to patients suffering from lipid metabolism, the bioavailability of the hydroxylated form of vitamin D was found to be 10 times higher compared to the non-hydroxylated form. Greater retention of the hydroxylated form of vitamin D could be the reason for this. Thus, hydroxylated forms increase bioavailability (Silva and Furlanetto91).

Vitamin D molecular linkage

For the physicochemical linkage of vitamin D, physical modification, namely emulsification, encapsulation, and nanoencapsulation, showed higher bioavailability of vitamin D than chemical modification (esters and salts of vitamin D)92. In another study, the efficiencies of three delivery systems of vitamin D were studied: microencapsulated, micellized, and oil-based. Microencapsulated and oil-based forms were more bioavailable than micellized vitamin D3 vehicles, and the microencapsulated form remained constant for the longest period, indicating more bioavailability. Micellization is a fat-soluble nutrient delivery method in which surfactants are used to micronize nutrients into water-soluble micellar spheres. When the surfactant monomer concentration reaches critical micelle concentration, then self-assembling of surfactants and micelle formation starts. Vitamin D3 was micellized using macrogol glycerol ricinolate. The area under the curve pharmacokinetics analysis was studied, and it was observed that micellized vitamin D3 had lower bioavailability than the other two forms93.

Food matrix and its complexity

Vitamin D needs to be drawn out from the food matrices to make it available for absorption into the enterocytes. Two studies were performed in rats, and it was observed that there is bioavailability of vitamin D2 in UV-irradiated mushrooms, but no comparisons were made for the bioavailability with other matrices94,95. A study observed the same bioavailability of a vitamin D2 supplement as compared to button mushrooms, which underwent UV-B irradiation96. This conclusion was supported when bioavailability of fortified wheat bread, rye bread, and supplements were compared, and no change in the increase pattern was observed. Thus, the food matrix does not affect vitamin D bioavailability92.

Vitamin D state

Lorentzon and Danielson97 observed higher absorption of intestinal vitamin D during the condition of vitamin D deficiency. Research was conducted in which rats were kept vitamin D deficient for 2 months, and three forms of radiolabeled cholecalciferol were administered for 9 days. The results showed that animals with vitamin D deficiency accumulated higher than its counterparts (Lorentzon & Danielsson97; Silva & Furlanetto91). A study reported a 50% elevation in serum 25(OH)D levels after ingesting the largest meal of the day. Increasing the secretion of particular food components or digestive enzymes might be the reason92,98.

Lipids

Lipids play a significant role in the vitamin D transport process. Fat-soluble food is solubilised by diffusion, and micelle formation occurs due to the secretion of bile juice by lipids. Fatty acids, monoglycerides, and phospholipids are released as a result of catalysis of lipids with digestive enzymes, and more micelles are formed, which in turn helps in solubilizing lipophilic nutrients. Lipids transport lipophilic nutrients out of the enterocyte to prevent vitamin D accumulation, thereby increasing vitamin D absorption. However, studies reported no significant difference when vitamin D bioavailability in two beverages, namely milk and orange juice, was eval‎uated. It was found that the lipid content in milk did not affect the bioavailability of vitamin D significantly99. In another study, when rats were fed 2.5 mM fatty acids of different chain length and degree of saturation was observed, vitamin D absorption was found to decrease100. Similar reports were seen when no elevation in vitamin D absorption was observed after ingesting 2 g of fish oil per week (Hollander et al. 100; Maurya and Aggarwal92).

Studies report that cholesterol and other factors hinder cholesterol uptake. Long-chain fatty acids and phytosterols are found to be responsible for decreasing vitamin D absorption. Hollander et al. observed that the rate of absorption of vitamin D3 decreased with supplementation of 2.5 mM fatty acids with different chain lengths and saturation levels. Oleic and linoleic acids showed a higher increase in inhibition when compared to octanoic acid. Long -chain fatty acids hinder vitamin D absorption by increasing the micellar particle size and slowing their passage towards enterocytes unlike medium-chain fatty acids92,100. In another study, at different stages of intestinal absorption, the effect of long chain fatty acid was tested and cholecalciferol uptake was found to decrease in Caco-2 cells, which might partially be due to gene coding modulation for lipid transport proteins101. Another study reported that a MUFA-rich diet increased vitamin D bioavailability more than a PUFA-rich diet. Thus, fatty acid species affect the efficacy of vitamin D absorption.

Dietary fibre

Dietary fibre is presumed to affect vitamin D absorption by hindering micelle formation, lipolysis of triacylglycerol and emulsification. Lipophilic food nutrients containing micelles at the brush boarder decrease diffusion, thereby increasing the viscosity of chyme. Ingestion of high dietary fibre has led to decreased absorption of vitamin D in Asian immigrants with increased occurrence of rickets and osteomalacia102. This conclusion was supported by a study on the relative disappearance of plasma on radiolabelled 25(OH)D3 performed on healthy volunteers with a normal diet or a high fibre diet. The mean serum half-life of 3H-25(OH)D3 in the high fibre group was observed to be significantly shorter than the normal diet group92,103. Recent research was conducted to identify the impact of chitosan on vitamin D bioavailability using an in vitro digestion model. Chitosan decreased the bio-accessibility of vitamin D by 37% and was suggested to release bound free fatty acids during lipid digestion104. However, in another study of two groups consuming wheat bread with a lesser amount of fibre and rye bread with rich fibre content and vitamin D fortification, no difference was observed in serum levels of 25(OH)D. Thus, the data is too insignificant to deduce the consequence of dietary fibre in vitamin D bioavailability, and more research is required92.

Ageing

Physiological changes and aging might directly or indirectly affect vitamin D absorption. A vitamin A and D absorption study was done on rats aging 6, 12, and 24 months. Radioactive forms of vitamins A and D were fed through a stomach tube and a percentage of absorption was determined. Age did not significantly affect the absorption of vitamins A and D under the conditions of this investigation105. Another study was conducted on 20 elderly women and a low serum [3H] cholecalciferol level was observed due to a less efficient gastrointestinal tract in comparison to younger females106. Reduced synthesis of vitamin D in the skin, lesser contact with the sun’s UV-B, and reduced consumption of vitamin D-rich foods could result in variation of serum 25(OH)D levels.

Disease and surgery

Vitamin D absorption requires normal digestive function. Diseases that lead to impaired fat absorption are suspected to hinder vitamin D absorption. Studies showed that infants and children with extrahepatic biliary atresia had undetectable serum vitamin D2 and D3, despite oral supplementation. Oral vitamin D2 absorption was reduced to one-third or one-half for cystic fibrosis patients88. In another study, a single oral dose of 50,000 IU vitamin D2 was administered to 7 intestinal malabsorption syndrome patients and 7 healthy individuals. An increase in serum vitamin D concentration was observed within 4 h, reaching peak levels by 12 h, and returning to baseline within 3 days in healthy individuals107. Likewise, the association was studied between the status of vitamin D and disease activity in Crohn’s disease, and it was found to be inversely associated with the disease activity indicators108. Another study was conducted to test the consequence of Roux-en-Y bariatric surgery on intestinal cholecalciferol absorption. A single oral dose of 50000 IU solubilised cholecalciferol was administered and checked after 1, 2, 3, and 14 days. The levels decreased from 92.0 + _6.5 to 63.5 + _10, stating 30% lower peak serum cholecalciferol levels109.

Vitamin D in the management of NCDs

Cancer

Uncontrolled proliferation of cells due to genes modifications by mutations, environmental factors, pollution, smoking, alcohol consumption, etc., causes cells to not react at cell cycle checkpoints, which promotes cell growth and metastasis110. Cancer is caused by upregulation in the oncogene’s activities and downregulation of tumour suppressor genes111. Different cancers appear with different signs and symptoms. For breast cancer, there is a lump in the breast along with increased size, change in colour, bleeding, and itching. Likewise, stomach cancer involves pain in the abdomen, weight loss, nausea, loss of appetite, and vomiting. Pain, weight loss, loss in appetite, swelling, and the formation of lumps are some of the common signs observed in cancer patients112. McCollum et al. discovered vitamin D to be the treatment for rickets about a century ago. Interest in vitamin D and related research has been increasing due to the rise in vitamin D insufficiency in children and people around the world, as well as the revelation of facts regarding the health benefits of vitamin D113. Vitamin D serves as a precursor to the steroid hormone calcitriol (1,25-dihydroxy vitamin D3 (1,25(OH)2D3)), which regulates several bodily functions114. Vitamin D deficiency increases the risk of cancer, as well as other diseases115. Some studies reported that vitamin D negatively impacts the preval‎ence of malignancy. Calcitriol activity is moderated via vitamin D receptor (VDR), a nuclear receptor, through genomic actions. The involvement of non-genomic pathways also help in calcitriol’s rapid actions. VDR shows its expression‎ in every cell and in tissues associated with calcium regulation, as well as in malignant cells114. VDR is found in the kidneys, bones, and gut, and regulates a variety of signalling pathways: cell proliferation, apoptosis, differentiation, inflammation, invasion, and angiogenesis116,117. Vitamin D affects the differentiation, growth, and death of monocytes, dendritic cells, and several types of T cells by modulating the mechanisms involved in cancer cell growth (Silva et al. 118). Calcitriol leads to the inhibition of malignant melanoma cell proliferation and differentiation of HL-60 leukaemia cells into macrophages. Calcitriol has been demonstrated to affect cell development in cancer cells by altering the expression‎ and activity of critical growth factors. Individuals with a fiery gut infection and a lack of vitamin D have a significantly greater possibility of developing colon cancer. In many actions in colon metastatic cells, there is inhibition of β-catenin transcriptional activity, which distorts the activation of WNT–β-catenin signalling, the most well-known modification in colorectal cancer115. Calcitriol stops the development of numerous harmful cells by introducing cell cycle arrest and accumulating the cells in the G0/G1 phase of the cell cycle. In the case of prostate cancer cells, calcitriol enhances the expression‎ of cyclin-dependent inhibitors p21 and p27, and also downregulates cyclin-dependent kinase 2 and arrests cells at G1/G0 phase. Calcitriol elevates the expression‎ of p73, which is a homologue of p53 (a tumour suppressor gene). Calcitriol-induced apoptosis is abrogated by suppression of p73119. Studies have reported that calcitriol directs cell development by regulating the expression‎ and activity of key growth factors in cancer cells. Calcitriol in prostate cancer cells enhances the expression‎ of the insulin-like growth factor protein -3 (IGBP-3), which suppresses cell growth by increasing the expression‎ of p21. In prostate and breast cancer cells, calcitriol activated the mitochondrial-dependent apoptotic pathway by decreasing the expression‎ of antiapoptotic proteins such as Bax and Bad. Caspases induce apoptosis after becoming activated by calcitriol114 (Fig. 3).

Fig. 3: Role of vitamin D in the inhibition of cancer cells by targeting genes associated with cell proliferation pathways.

(IGBP- Immunoglobin binding protein; p21- also known as wildtype activating factor-1/cyclin-dependent kinase inhibitor protein-1; VEFG-Vascular endothelial growth factor). (This Figure was created by the authors).

Full size image

Studies reported that living at lower latitudes and increased sun exposure lead to more endogenous vitamin D3 synthesis, decreasing the chances of colorectal cancer120. There are studies that showed a 30–40% lower colorectal cancer risk in patients with sufficient vitamin D levels than in patients with lower vitamin D levels Zhou et al. 11. Experimental evidence indicates that vitamin D has antineoplastic activity in malignant cells. Vitamin D binding to the vitamin D receptor prompts transcriptional activation and repression of target genes and results in introducing differentiation and apoptosis, suppression of cancer stem cells, downregulating growth, angiogenesis, and metastatic potential. There are many observational studies available that show that increased plasma 25-hydroxyvitamin D levels lessen the chances of colorectal cancer121.

Various studies have been performed to identify the relationship between vitamin D3 serum concentration and progression/development of breast cancer. 1,25(OH)2D3 retarded the growth of breast cancer cells from the G0/G1 phase to the S phase of the cell cycle and also increased the expression‎ of cyclin dependent kinases (CDKS)117. Osteoporosis is typically seen in patients who survived post-menopausal breast cancer122. There are some cancer cases based on occupational categories, including lip cancer and lung cancer, due to long-term UV-B exposure. Randomized clinical trials showed that vitamin D intervention affects the incidence of cancer123. Usually, in the case of cancer cells, there is inhibition of apoptotic pathways allowing cancer cells to live longer and mutations to occur. Due to the gene regulation of vitamin D, in several cancerous cells such as MDA-MB-231, MCF-7, LoVo, HT29, HCT116, LNCaP, DU-145, and PC-3, there is an increase in the expression‎ of apoptosis-inducing genes such as BAX, BAK1, and BAG1, and a downregulation of anti-apoptotic genes like BCL-2 and BCL-XL. Apart from these, vitamin D also triggers apoptosis by cell-specific mechanisms and downstream events124. Studies reported that daily supplementation with vitamin D decreases the chances of cancer mortality by approximately 13%, mainly in older people. Some of the known mechanisms involved are increased apoptosis, antiproliferative effects, immunomodulation, and the role of angiogenesis125. Vitamin D retarded angiogenesis by restricting VEGF expression‎ and repressing hypoxia-inducible factor 1 alpha and interleukin-8. Vitamin D inhibits invasion and metastasis by regulating plasminogen activator components as well as MMPs (Varghese et al., 2020). Food fortification with vitamin D plays a role in the reduction of cancer preval‎ence, as fortification increases serum D3 levels125. To the best of our knowledge, the majority of the studies indicated a positive correlation between vitamin D and cancer prevention.

CVDs

There are various chronic risk factors associated with the development or progression of CVDs126. Rheumatic heart disease, peripheral arterial disease, coronary heart disease (CHD), cerebrovascular disease, deep vein thrombosis, or congenital heart disease are some commonly diagnosed CVDs. CVD is the major non-communicable cause of death in Europe (50 percent of all fatalities; 30% of all deaths worldwide)127. In 2008, nine million persons died prematurely from non-communicable diseases before the age of 60; roughly eight million of these early deaths occurred in low and middle-income countries128. Stroke and ischaemic heart disease (IHD) were the two primary causes of CVD health loss in each world region. By 2030, CVDs will kill more than 22.2 million people every year. Cardiomyocytes, vascular endothelial cells, fibroblasts, and smooth muscle cells all indicate vitamin D receptor (VDR) and the enzyme 1-hydroxylase, both of which are necessary for the synthesis of vitamin D’s active form. Smooth vascular muscle cell proliferation is stimulated, renin-angiotensin-aldosterone system (RAAS) activity is inhibited, and the release of natriuretic peptide is also inhibited129. Vitamin D is hypothesised to protect against cardiovascular disease because its receptor, VDR, is intracellular and can bind to 1,25(OH)2D3. This causes VDR to bind to the retinoid X receptor (RXR), after which it transfers to the nucleus, where it attaches to the regulator site of the DNA sequence promoter region, resulting in enhanced production of vitamin D-regulated proteins130, as shown in Fig. 4.

Fig. 4: Regulation of the biosynthesis of vitamin D - regulated protein: VDR is intracellular and can bind to 1,25(OH)2D3.

This causes VDR to bind to the retinoid X receptor (RXR), translocate to the nucleus, and bind to the regulator site in the promotor region of DNA sequence elements. This in turn boost the synthesis of vitamin D-regulated proteins. (VDR: Vitamin D receptor; RXR: retinoid X receptor; VDRE: Vitamin D Response Element). (This Figure was created by the authors).

Full size image

Vitamin D receptors have been found in the majority of cardiovascular cell types, such as endothelial cells, vascular smooth muscle cells, as well as in immune cells such as dendritic cells, macrophages, and others131. It has been identified that the expression‎ of the VDR declines with age. Vitamin D enters the nucleus via the cell membrane and cytoplasm and binds to VDR. When this combination binds to the RXR, it changes gene function and stimulates protein production. In the liver, the vitamin D binding protein is produced, which is 58 kDa in weight and serves as the primary calcitriol transporter. Its roles include stimulation of macrophages, actin clearance, and fatty acid binding, which aid vitamin D in reaching its target tissues. Multiplicity in vitamin D binding proteins may influence vitamin D binding affinity and may be linked to the threat of vitamin D insufficiency or CVD132. By activating nuclear VDR in cardiomyocytes and vascular endothelial cells and altering the renin-angiotensin-aldosterone system, pancreatic cell activity, obesity, and energy expenditure, vitamin D has CV pleiotropic effects133. Experimental models have shown that vitamin D has a variety of cardiovascular effects, involving suppression of cardiomyocyte proliferation and promotion of vascular smooth muscle cell proliferation134. In particular, myocardial, renal arteries, and kidney tissue can suppress the expression‎ of angiotensin I and the synthesis of angiotensin II when VDR is activated by calcitriol or its analogues135,136. Immune cells lacking VDR have been shown to have a direct influence on miR-106b-5p release, which may then boost renin production by acting on juxtaglomerular cells, implying that inflammation may be a contributing factor to renin-driven hypertension116. Research is still being conducted regarding the role of vitamin D in the treatment of CVDs. According to certain research, vitamin D deficiency may raise the threat of CVDs. Blood pressure regulation, endothelial function improvement, and inflammation reduction may all work together to lower the risk of developing CVDs137. Coronary artery disease, heart failure, and stroke are among the conditions known as CVDs, which affect the heart and blood arteries. Vitamin D has been shown to be associated with a decrease in incidences of CVDs. Inflammation, blood pressure, and blood sugar regulation are all factors that contribute to CVDs and may be reduced by vitamin D Zhou et al. 138. To the best of our knowledge, the majority of the studies indicate a positive correlation of vitamin D and the prevention of CVDs. Further, supplementation with vitamin D has also shown a positive impact on post CVDs conditions, as indicated in aforementioned studies.

Hypothyroidism

The thyroid gland is one of the major endocrine glands, playing a variety of homoeostatic control roles, such as growth, energy expenditure, and metabolism. Any thyroid disorder can cause a variety of metabolic issues139. The preservation of several essential activities in both adults and children depends on thyroid hormones. For maintaining health and supporting optimal growth and development of the body, appropriate thyroid hormone levels are necessary140. All hormones of the thyroid are dependent on maternal thyroxin (T4) transported through the placenta since the foetal thyroid gland does not develop until around 18–20 weeks of pregnancy141. Thyroid-binding globulin (TBG) levels also increase in the blood during pregnancy. When paired with free triiodothyronine (fT3) and free T4 (fT4), a modest drop in these two hormones (10–15%) results in pregnant women who reside in areas with adequate iodine. Vitamin D may also aid in the treatment of hypothyroidism, according to research. Hypothyroidism develops when the thyroid gland does not produce enough thyroid hormone142. This slows down the metabolism and causes a number of symptoms like fatigue, weight gain, and sadness. Some studies suggest that taking vitamin D supplements may assist patients with hypothyroidism, improving thyroid function and having less severe symptoms143. To complete comprehension, thorough research is needed to identify the association of vitamin D in the occurrence of hypothyroidism. Vitamin D plays a role in thyroid function modulation. Moreover, a lack of vitamin D may exacerbate hypothyroidism symptoms and hasten the onset of autoimmune thyroid disease144. In conclusion, vitamin D is crucial for the treatment of hypothyroidism. A sufficient amount of vitamin D may assist control of thyroid function and guard against the onset of heart disease. Those with these health issues should consult their doctor to be sure they are getting enough vitamin D through their diet or supplements. Thus, most studies indicate the positive correlation of vitamin D and thyroid prevention.

Diabetes mellitus

Diabetes mellitus is characterized by chronic hyperglycaemia. It has been classified into three major types: Type 1 or insulin dependent diabetes mellitus (IDDM), Type 2 or non-insulin dependent diabetes mellitus (NIDDM), and gestational diabetes145. Type 1 is caused by absolute insulin deficiency, which results due to destruction of β-cells. It is also known as LADA (latent autoimmune diabetes in adults)145. In type 2 diabetes mellitus, the pancreas is able to produce insulin; however, the insulin resistance or insulin deficiency is observed. In gestational diabetes, glucose tolerance impairments are observed during pregnancy. Gestational diabetes is also associated with development an increased risk of type 2 diabetes in later stages of life146. Currently, the global population is afflicted by this NCD, and it claims over four million lives annually147. By 2045, nearly 11% of the global population is expected to suffer from either diabetes or its complications147. This metabolic disorder is caused by numerous factors associated with lifestyle choices, like physical inactivity, inadequate nutrient consumption, and other epigenetic factors. Nutrigenomics studies have also highlighted the fact that the occurrence of diabetes is linked to epigenetic factors and nutritional imbalances as well. Vitamin D has also been linked with modification in the risk of the occurrence of diabetes. Several mechanisms involved in the pathogenesis of type 2 diabetes ---such as decreased insulin action, systemic inflammation, and malfunction of the pancreatic beta cells-- are influenced by vitamin D both directly and indirectly. According to observational studies, decreased blood levels of 25-hydroxyvitamin D is linked to an increase in the chances of type 2 diabetes148. Most insulin resistance-related conditions reported to date appear to be linked to poor vitamin D status148. A randomized controlled trial in 1720 pregnant women showed that the supplementation of vitamin D3 (1600 IU/d) to an experimental group led to the prevention of mid-late gestation diabetes as compared to a control group with supplementation of only 400 IU/d of vitamin D3, leading to an increase in fasting plasma glucose (FPG) levels149. However, numerous other randomized trials aimed at identifying the relationship between vitamin D intervention and decreased occurrence of diabetes (both Type 1 and Type 2) did not show any significant association150,151. Therefore, the studies indicated a need for more research to analyse the co-relation of vitamin D and diabetes prevention.

Osteoporosis

Osteoporosis is a skeletal disorder associated with reduced bone strength and an increased risk of fractures, including those of hip and vertebral fractures (Aspray & Hill,152; Muñoz et al. 153). Osteoporosis is characterised by a decrease in mineral density and mass of bones, thereby making the bones weak and brittle and more susceptible to the occurrence of fracture. In the literature, osteoporosis has been referred to as a “silent” disorder because it does not have any symptoms154. The disease becomes apparent when fractures occur due to the fragility of bones in unexpected situations, such as fractures caused by coughing, bending, lifting or fall from standing height. Osteoporosis has been classified into two types: primary, and secondary. Primary osteoporosis occurs in postmenopausal women and men due to age- associated changes in the body155. Contributing factors for secondary osteoporosis are diseases, treatments, drugs, genetic or such epigenetic factors as improper nutrition, insufficient intake of vitamin D and calcium, hormonal imbalances such as oestrogen deficiency156, consumption of alcohol, smoking, inadequate body mass index (BMI), and decrease in physical activity157,158. According to the World Health Organization (WHO), osteoporosis is “bone mineral density (BMD) that lies 2.5 standard deviations or more below the average value for young, healthy individual”155. In context to nutritional research, vitamin D deficiency is closely linked with the onset of osteoporosis159. Currently, the use of medications, dietary interventions, such as sufficient intake of proteins and trace elements like calcium and vitamin D, and lifestyle management is suggested for reducing the risks associated with this silent disease. However, the occurrence of this disease has been associated with significant morbidity and mortality156. In such a scenario, the prevention of this disease itself should be a public health priority. Vitamin D and calcium intervention or adequate intake for prevention of this disease remains an essential factor. 25(OH)D is converted to 1,25(OH)2D in the kidneys, and it is responsible for opening of calcium channels in the gut. The opening of calcium channels is followed by the formation of calcium binding proteins. This cascade is responsible for the absorption of calcium and phosphate, the essential bone health minerals from the gut, thereby leading to passive bone mineralization157. In cases of prolonged vitamin D deficiency, bone loss and risk for osteoporosis is observed. This occurs due to increased bone turnover in the presence of elevated serum parathyroid hormone (PTH) levels and decreased serum vitamin D levels160. These conditions work against the process for stimulation of calcium absorption. The case of osteomalacia, i.e., bone softening, is also observed due to vitamin D deficiency as the volume of osteoid tissue accumulates to a percentage in the absence of adequate mineral absorption157. Deficient and insufficient serum 25(OH)D levels have been linked with bone mineral density in numerous studies. In clinical trials, vitamin D supplementation (400 to 1000 IU/ day depending upon the deficient needs) among individuals tagged with calcium doses (500 to 1200 mg/d) has shown a potential increase in bone mineral density157. This increase in bone mineral density stopped after two years following the discontinuation of this combined micronutrient supplementation in a study conducted among elderly men and women161.

What lies ahead?

•  
•  
•  
•  
•  
•  

Conclusions

Vitamin D deficiency is preval‎ent worldwide in both developing and developed countries. Deficient levels of serum 25 (OH) D indicate the sufficiency, insufficiency, or deficiency of this nutrient. The RDAs and dosage for the management of levels of this nutrient are frequently debated and are specific from country to country depending upon epigenetic factors. The bioavailability of this nutrient also depends upon factors such as age (which can lead to reduced VDR counts and less efficient GI tract), a high amount of fibre in the diet hindering the micelle formation, and the presence of long chain fatty acids and phytosterols in high amounts. The food matrix might not affect the bioavailability of vitamin D absorption, as per present literature. However, various factors hinder the bioavailability of this micronutrient, and so research focusing absorption and availability of vitamin D in the body is necessary. Advanced inputs, such as encapsulation via atomization, electro-spinning, and electro-spraying into nano-suspensions, nano-emulsion, nano-liposome, and cyclodextrin carriers, are being utilized and researched. The current rapid ride in VDD cases of and its impact for prevention and onset of numerous diseases underscores the importance of studies regarding this vitamin and its associated effects for clear mechanisms.

Data availability

Data sharing is not applicable, as this is a review article and no new datasets were generated or analyzed during this study.

References

1.  
2.  
3.  
4.  
5.  
6.  
7.  
8.  
9.  
10.  
11.  
12.  
13.  
14.